Page last updated: 2024-09-02

2-acetyl-4(5)-tetrahydroxybutylimidazole and Diabetes Mellitus, Type 1

2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koulmanda, M; Mackay, IR; Mandel, TE1

Other Studies

1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and Diabetes Mellitus, Type 1

ArticleYear
Prevention of spontaneous and cyclophosphamide-induced diabetes in non-obese diabetic (NOD) mice with oral 2-acetyl-4-tetrahydroxybutylimidazole (THI), a component of caramel colouring III.
    Clinical and experimental immunology, 1992, Volume: 88, Issue:3

    Topics: Administration, Oral; Animals; CD4 Antigens; CD8 Antigens; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Flow Cytometry; Imidazoles; Lymphopenia; Mice; Mice, Inbred NOD; Spleen; T-Lymphocytes; Thymus Gland

1992